Three lenses go head-to-head

Article

The implantation of multifocal and accommodative intraocular lenses (IOLs) can offer adequate near and far vision in addition to high levels of patient satisfaction.

The implantation of multifocal and accommodative intraocular lenses (IOLs) can offer adequate near and far vision in addition to high levels of patient satisfaction, according to Georgio Marchini and colleagues from the University of Verona, Italy.

The researchers enrolled 120 eyes (60 patients) to undergo bilateral phacoemulsification and split the patients into three groups of 40 eyes. Group 1 received the diffractive ReSTOR (Alcon), Group 2 received the refractive ReZoom (AMO) and Group 3 received the accommodative Crystalens AT-45 (Eyeonics).

The results demonstrated that there were no statistical differences in uncorrected distance visual acuity (UCDVA) and best corrected distance visual acuity (BCDVA) among the three groups. Those in the ReStor group did, however, achieve better uncorrected near visual acuity (UCNVA) and best distance corrected near visual acuity (BDCNVA). Bigger accommodative amplitude and better contrast sensitivity, with and without glare, was noted in the Crystalens group.

It was concluded that, although each lens provides adequate visual acuity, the ReStor lens performs best in near vision, the Crystalens and ReZoom offer more useful accommodative amplitude and the Crystalens also offers better contrast sensitivity.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.